Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Crucell patents

Patents where

Current Assignee

Name

Crucell

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 6974695 Complementing cell lines	Patent 6974695 was granted and assigned to Crucell on December, 2005 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	6974695	December 13, 2005
‌ US Patent 7033834 Methods and means for targeted gene delivery	Patent 7033834 was granted and assigned to Crucell on April, 2006 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	7033834	April 25, 2006
‌ US Patent 7833788 Production of vaccines	Patent 7833788 was granted and assigned to Crucell on November, 2010 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	7833788	November 16, 2010
‌ US Patent 7105346 Packaging systems for human recombinant adenovirus to be used in gene therapy	Patent 7105346 was granted and assigned to Crucell on September, 2006 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	7105346	September 12, 2006
‌ US Patent 6869794 Complementing cell lines	Patent 6869794 was granted and assigned to Crucell on March, 2005 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	6869794	March 22, 2005
‌ US Patent 7192759 Production of vaccines	Patent 7192759 was granted and assigned to Crucell on March, 2007 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	7192759	March 20, 2007
‌ US Patent 7521220 Production of vaccines	Patent 7521220 was granted and assigned to Crucell on April, 2009 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	7521220	April 21, 2009
‌ US Patent 7732129 Method for the production and purification of adenoviral vectors	Patent 7732129 was granted and assigned to Crucell on June, 2010 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	7732129	June 8, 2010
‌ US Patent 8124106 Virus purification methods	Patent 8124106 was granted and assigned to Crucell on February, 2012 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	8124106	February 28, 2012
‌ US Patent 7270811 Serotype of adenovirus and uses thereof	Patent 7270811 was granted and assigned to Crucell on September, 2007 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	7270811	September 18, 2007
‌ US Patent 8052967 Stable adenoviral vectors and methods for propagation thereof	Patent 8052967 was granted and assigned to Crucell on November, 2011 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	8052967	November 8, 2011
‌ US Patent 7262028 Recombinant production of mixtures of antibodies	Patent 7262028 was granted and assigned to Crucell on August, 2007 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	7262028	August 28, 2007
‌ US Patent 7285265 Stable adenoviral vectors and methods for propagation thereof	Patent 7285265 was granted and assigned to Crucell on October, 2007 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	7285265	October 23, 2007
‌ US Patent 7387894 Recombinant viral-based malaria vaccines	Patent 7387894 was granted and assigned to Crucell on June, 2008 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	7387894	June 17, 2008
‌ US Patent 7524947 Recombinant viral-based malaria vaccines	Patent 7524947 was granted and assigned to Crucell on April, 2009 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	7524947	April 28, 2009
‌ US Patent 7521229 Recombinant viral-based malaria vaccines	Patent 7521229 was granted and assigned to Crucell on April, 2009 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	7521229	April 21, 2009
‌ US Patent 7329530 Chimaeric phages	Patent 7329530 was granted and assigned to Crucell on February, 2008 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	7329530	February 12, 2008
‌ US Patent 8192927 Human bind molecules capable of neutralizing influenza virus h5n1 and uses thereof	Patent 8192927 was granted and assigned to Crucell on June, 2012 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	8192927	June 5, 2012
‌ US Patent 8470327 Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof	Patent 8470327 was granted and assigned to Crucell on June, 2013 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	8470327	June 25, 2013
‌ US Patent 6913922 Serotype of adenovirus and uses thereof	Patent 6913922 was granted and assigned to Crucell on July, 2005 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	6913922	July 5, 2005
‌ US Patent 7429486 Recombinant production of mixtures of antibodies	Patent 7429486 was granted and assigned to Crucell on September, 2008 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	7429486	September 30, 2008
‌ US Patent 7901919 Chimaeric phages	Patent 7901919 was granted and assigned to Crucell on March, 2011 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	7901919	March 8, 2011
‌ US Patent 7579446 Binding molecules capable of neutralizing rabies virus and uses thereof	Patent 7579446 was granted and assigned to Crucell on August, 2009 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	7579446	August 25, 2009
‌ US Patent 7297680 Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content	Patent 7297680 was granted and assigned to Crucell on November, 2007 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	7297680	November 20, 2007
‌ US Patent 7740852 Binding molecules capable of neutralizing rabies virus and uses thereof	Patent 7740852 was granted and assigned to Crucell on June, 2010 by the United States Patent and Trademark Office.	Crucell	United States Patent and Trademark Office	7740852	June 22, 2010

...

Results per page:

133 results

0 selected

133 results

0 selected